Presentation is loading. Please wait.

Presentation is loading. Please wait.

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP) 

Published byInken Waltz Modified over 5 years ago

Similar presentations

Presentation on theme: "Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP) "— Presentation transcript:

1 Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)  Rohit Bhuriya, MD, Suying Li, PhD, Shu-Cheng Chen, MS, Peter A. McCullough, MD, MPH, George L. Bakris, MD  American Journal of Kidney Diseases  Volume 53, Issue 4, Pages S3-S10 (April 2009) DOI: /j.ajkd Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

2 Figure 1 Cardiovascular disease prevalence stratified by parathyroid hormone (PTH) level. P < for Cochran-Armitage trend test. PTH levels expressed in pg/mL and ng/L are equivalent. American Journal of Kidney Diseases  , S3-S10DOI: ( /j.ajkd ) Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

Download ppt "Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP) "

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease  Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease  Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.
Quiz Page April 2011 American Journal of Kidney Diseases

Quiz Page April 2011 American Journal of Kidney Diseases
Uric Acid and Long-term Outcomes in CKD

Uric Acid and Long-term Outcomes in CKD
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.
Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A

Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A
Peter A. McCullough, MD, MPH, Timothy Larsen, DO, Jeremiah R

Peter A. McCullough, MD, MPH, Timothy Larsen, DO, Jeremiah R
Peritoneal dialysis American Journal of Kidney Diseases

Peritoneal dialysis American Journal of Kidney Diseases
Quiz Page March 2008 American Journal of Kidney Diseases

Quiz Page March 2008 American Journal of Kidney Diseases
Francesca Mallamaci, MD, Giovanni Tripepi, PhD 

Francesca Mallamaci, MD, Giovanni Tripepi, PhD 
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.

Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 

Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
A Decade After the KDOQI CKD Guidelines

A Decade After the KDOQI CKD Guidelines
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.
Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)  Peter A. McCullough,

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)  Peter A. McCullough,
Determinants of Plasma Adiponectin Levels in Nondiabetic Subjects With Moderate to Severe Chronic Kidney Disease  Luis F. Ramos, MD, Ayumi Shintani, PhD,

Determinants of Plasma Adiponectin Levels in Nondiabetic Subjects With Moderate to Severe Chronic Kidney Disease  Luis F. Ramos, MD, Ayumi Shintani, PhD,
Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey  Varun Agrawal, MD, Amit K.

Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey  Varun Agrawal, MD, Amit K.
Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP) 

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP) 

Similar presentations

Ads by Google